Targeted Myeloma Treatments Bring Hope for Fewer Side Effects and Curative Therapy

January 21, 2014

Multiple Myeloma, Treatment

Dr. James Berenson discusses the importance of using maintenance therapies with limited short- or long-term side effects, in particular avoiding therapies that have long-term toxicity. Dr. Berenson expresses his excitement that within the next few years there is hope for curative therapy by using drugs that are “piggybacked” and delivered at a “thousand folds” higher rate to hit only the myeloma cells, versus the entire body.



Comments are closed.